Effects of perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery

Spine

Volumn 35, Issue 3, 2010, Pages 340-346

  Schwarzkopf, Ran ^a   Chung, Christine ^a   Park, Justin J ^a   Walsh, Michael ^a   Spivak, Jeffrey M ^a   Steiger, David ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Lumbar spinal surgery; Perioperative blood products; Surgical site infection; Thoracic spinal surgery

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SPINE SURGERY; SURGICAL INFECTION; THORACIC SPINE;

BLOOD COMPONENT TRANSFUSION; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; THORACIC VERTEBRAE;

EID: 76449095276     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181b86eda     Document Type: Article

References (59)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442
2. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20: 247-278
3. Boyce JM, Potter-Bynoe G, Dziobek L. Hospital Reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990;11:89-93.
4. Poulsen KB, Bremmelgaard A, Sorensen AI, et al. Estimated costs of postoperative wound infections: a case-control study of marginal hospital and social security costs. Epidemiol Infect 1994;113:283-295
5. Vegas AA, Jodra VM, Garcia ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993;9:504-510
6. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1900s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725-730
7. Gil-Egea MJ, Pi-Sunyer MT, Verdaguer A, et al. Surgical wound infections: prospective study of 4486 clean wounds. Infect Control 1987;8:277-280
8. Nagachinta T, Stephens M, Reitz B, et al. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 1987;156:967-973
9. Olsen MA, Nepple JJ, Riew D, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008;90: 62-69
10. Bryan AJ, Lamarra M, Angelini GD, et al. Median sternotomy wound dehiscence: a retrospective case control study of risk factors and outcome. J R Coll Surg Edinb 1992;37:305-308
11. Jones JK, Triplett RG. The relationship of cigarette smoking to impaired intraoral wound healing: a review of evidence and implications for patient care. J Oral Maxillofac Surg 1992;50:237-239
12. Slaughter MS, Olson MM, Lee JT Jr, et al. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thorac Surg 1993;56:1063-1068
13. B'erard F, Gandon J. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 1964;160(suppl 1):1-192.
14. Fang A, Hu SS, Endres N, et al. Risk factors for infection after spinal surgery. Spine 2005;30:1460-1465
15. Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg 1973;107:206-210
16. Claesson BE, Holmlund DE. Predictors of intraoperative bacterial contamination and postoperative infection in elective colorectal surgery. J Hosp Infect 1988;11:127-135
17. Vamvakas EC, Carven JH. Transfusion of white-cell-containing allogeneic blood components and postoperative wound infection: effect of confounding factors. Transfus Med 1998;8:29-36.
18. Walz JM, Paterson CA, Seligowski JM, et al. Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. Arch Surg 2006; 141:1014-1018
19. Talbot TR, D'Agata EMC, Brinsko V, et al. Perioperative blood transfusion is predictive of poststernotomy surgical site infection: marker for morbidity or true immunosuppressant? Clin Infect Dis 2004;38:1378-1382
20. Rughavan M, Marik PE. Anemia, allogenic blood transfusion and immunomodulation in the critically ill. Chest 2005;127:295-307.
21. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-845
22. Murphy PJ, Connery C, Hicks GL Jr, et al. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1992;104:1092-1099
23. Braga M, Vignali A, Radaelli G, et al. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992;158:531-536
24. Morris CD, Sepkowitz K, Fonshell C, et al. Prospective identification of risk factors for wound infection after lower extremity oncologic surgery. Ann Surg Oncol 2003;10:778-782
25. Tan MH, Mankin HJ. Blood transfusion and bone allografts: effect on infection and outcome. Clin Orthop 1997;340:207-214
26. Chang H, Hall GA, Geerts WH, et al. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang 2000;78:13-18
27. Vamvakas EC, Carven JH, Hibberd PL. Blood transfusion and infection after colorectal cancer surgery. Transfusion 1996;36:1000-1008
28. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-1333
29. Goodnough LT, Brecker ME, Kantor MH, et al. Transfusion medicine, blood transfusion. N Engl J Med 1999;340:438-447
30. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile Virus through blood transfusions in the United States in 2002. N Engl J Med 2003;349:1236-1245
31. Austyn JM. Antigen uptake and presentation by dendritic leucocytes. Semin Immunol 1992;4:227-236
32. Blajchman MA, Bordin JO. Mechanisms of transfusion associated immunosuppression. Curr Opin Hematol 1994;1:457-461
33. Jensen LS, AndersenAJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-516
34. Silliman CC, Boshkov LK, Mehdizadehkasi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-462
35. Van de watering LMG, Hermans J, Houbiers JGA, et al. Beneficial effect of leucocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: a randomised clinical trial. Circulation 1998;97:562-568
36. Edna TH, Bjerkeset T. Associations between blood transfusion and infection in injured patients. J Trauma 1992;33:659-661
37. Braga M, Vignali A, Radelli G, et al. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992;158:531-536
38. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229-1239
39. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusionassociated immunomodulation: fact or fiction? Blood 2001;97:1180-1195
40. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462-466
41. Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008;90: 62-69
42. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24:380-388
43. Hébert PC, Wells G, Blajchman MA, et al; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417
44. Berezina TL, Zaets SB, Morgan C, et al. Influence of storage on red blood cell rheological properties. J Surg Res 2002;102:6-12.
45. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red blood cell transfusion: when is it not safe? Crit Care Med 2003;31:687-697
46. Nielsen HJ, Reimert CM, Pedersen AN, et al. Time dependent, spontaneous release of white cell-and platelet-derived bioactice substances from stored human blood. Transfusion 1996;36:960-965
47. Bordin JO, Heddle NM, Blajchman MA. Biological effects of leucocytes present in transfused cellular blood products. Blood 1994;84:1703-1721
48. Hebert PC, Ferguson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukodepletion program fro red blood cell transfusion. JAMA 2003;289:1941-1949
49. Moonen AF, Thomassen BJ, Knoors NT, et al. Preoperative injection of epoetin alpha versus postoperative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomized clinical trial. JBJ Surg BR 2008;90-B:1079-1083
50. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alpha in critically ill patients. N Engl J Med 2007;357:966-976
51. Phrommintikul A, Haas SJ, Elsik M, et al. Mortality and target hemoglobin concentrations in patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007;369:381-388
52. Bohluis J, Wilson J, Sendenfeld WJ, et al. Erythropoietin or darbopoietin for patients with cancer. Cochrane Database Syst Rev 2006;3:CD003407.
53. Gill JB, Chin Y, Levin A, et al. The use of antifibrinolytic agents in spine surgery: a meta-analysis. J Bone Joint Surg Am 2008;90:2399-2407
54. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006;105: 1034-1046
55. Thompson GH, Florentino-Pineda I, Poe-Kochert C, et al. Role of Amicar in surgery for neuromuscular scoliosis. Spine 2008;33:2623-2629
56. Thompson GH, Florentino-Pineda I, Poe-Kochert C, et al. The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. Spine 2008;33:2237-2242
57. Florentino-Pineda I, Blakemore LC, Thompson GH, et al. The Effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: a preliminary prospective study. Spine 2001;26:1147-1151
58. Colomina MJ, Bagó J, Vidal X, et al. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid. Orthopedics 2009;32:91.
59. Elwatidy S, Jamjoom Z, Elgamal E, et al. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine 2008;33:2577-2580